MALIGNANT NEOPLASMS OF FEMALE GENITAL ORGANS
Clinical trials for MALIGNANT NEOPLASMS OF FEMALE GENITAL ORGANS explained in plain language.
Never miss a new study
Get alerted when new MALIGNANT NEOPLASMS OF FEMALE GENITAL ORGANS trials appear
Sign up with your email to follow new studies for MALIGNANT NEOPLASMS OF FEMALE GENITAL ORGANS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug combo aims to control Hard-to-Treat cancers
Disease control OngoingThis study tests a combination of two drugs, selumetinib and olaparib, in people with advanced or recurrent solid tumors (including ovarian, endometrial, breast, and others) that have specific genetic changes or have stopped responding to similar treatments. The first phase finds…
Matched conditions: MALIGNANT NEOPLASMS OF FEMALE GENITAL ORGANS
Phase: PHASE1 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Jun 27, 2026 12:08 UTC
-
Bacteria bombs target stubborn tumors in new cancer combo trial
Disease control OngoingThis study tests a special bacteria (Clostridium novyi-NT) injected directly into tumors, combined with the immunotherapy drug pembrolizumab, for people with advanced solid tumors that haven't responded to standard treatments. The bacteria are designed to break down tumor cells f…
Matched conditions: MALIGNANT NEOPLASMS OF FEMALE GENITAL ORGANS
Phase: PHASE1 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Jun 27, 2026 12:07 UTC
-
New drug combo shows promise for rare ovarian cancer
Disease control OngoingThis pilot phase II study tests whether the drugs fulvestrant and abemaciclib can help control low-grade serous ovarian cancer in women with advanced disease. Up to 18 participants will receive the drugs before and after surgery. The goal is to see how many patients achieve a par…
Matched conditions: MALIGNANT NEOPLASMS OF FEMALE GENITAL ORGANS
Phase: PHASE2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Jun 27, 2026 09:10 UTC
-
Can avastin stop ovarian cancer from coming back?
Disease control OngoingThis phase II trial tests whether the drug bevacizumab (Avastin) can help control ovarian, fallopian tube, or primary peritoneal cancer that is still present after initial treatment. About 35 women whose cancer was found during a second-look surgery will receive bevacizumab every…
Matched conditions: MALIGNANT NEOPLASMS OF FEMALE GENITAL ORGANS
Phase: PHASE2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Jun 27, 2026 09:02 UTC
-
Home workouts may help endometrial cancer survivors shed pounds
Symptom relief OngoingThis study tests whether a home-based weight loss program, with or without resistance training, is practical for endometrial cancer survivors. Fifteen participants will follow a program using a workbook, fitness tracker, and coaching calls. The goal is to see if they can lose wei…
Matched conditions: MALIGNANT NEOPLASMS OF FEMALE GENITAL ORGANS
Phase: NA • Sponsor: M.D. Anderson Cancer Center • Aim: Symptom relief
Last updated Jun 27, 2026 11:00 UTC